Posters Modérés (PM1) - Zone rose - Personnalisation des traitements (session 1)

• 93 • PM1-016 - Determination of probability of target attainment, based on a tacrolimus twice a day modelling in adult heart transplant patient using the through concentration and the area under the curve > A. Alexandre Destere • 162 • PM1-017 - Cefepime overexposure despite the use of recommended doses, a retrospective study in orthopedic surgery > N. Ngoc Hoa Truong • 167 • PM1-018 - Defining standard and high dosages for beta-lactams administered by intermittent, prolonged or continuous infusion: a PK/PD simulation study > S. Sylvain Goutelle • 192 • PM1-019 - A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir > F. Florian Lemaitre • 231 • PM1-020 - Dalbavancin plasma concentrations in 133 patients: a PK-PD observational study > M. Matthieu Gregoire • 263 • PM1-021 - Determination of the clindamycin dose to be administered by continuous infusion during combination therapy with rifampicin : a prospective population pharmacokinetics study. > L. Léo Mimram • 296 • PM1-022 - Nirmatrelvir/ritonavir: efficacy, safety and drug monitoring in a real-life cohort of outpatient liver transplant recipients > C. Camille Tron • 307 • PM1-023 - Fifteen-year large-scale retrospective analysis of mycophenolate mofetil Bayesian dose adjustment in adult liver transplant recipients > C. Caroline Monchaud